Sector
PharmaceuticalsOpen
₹223.3Prev. Close
₹222.1Turnover(Lac.)
₹12.51Day's High
₹227.95Day's Low
₹213.252 Week's High
₹247.452 Week's Low
₹103.55Book Value
₹55Face Value
₹10Mkt Cap (₹ Cr.)
308.76P/E
33.1EPS
6.62Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 12.59 | 12.59 | 12.59 | 12.04 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 34.51 | 27.97 | 26.7 | 23.05 |
Net Worth | 47.1 | 40.56 | 39.29 | 35.09 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 45.93 | 34.96 | 40.04 | 31.1 |
yoy growth (%) | 31.39 | -12.69 | 28.75 | -12.77 |
Raw materials | -7.57 | -5.17 | -6.97 | -5.71 |
As % of sales | 16.49 | 14.79 | 17.41 | 18.36 |
Employee costs | -13.73 | -12.11 | -13.2 | -9.95 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 3.16 | -3.27 | 0.09 | -2.77 |
Depreciation | -4.55 | -4.35 | -3.9 | -3.59 |
Tax paid | -0.71 | 0.79 | -0.02 | 1.44 |
Working capital | 0.04 | 1.69 | 5.05 | 2.96 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 31.39 | -12.69 | 28.75 | -12.77 |
Op profit growth | 97.03 | -32.85 | 64.98 | -50.64 |
EBIT growth | 280.34 | -61.5 | 110.47 | -69.56 |
Net profit growth | -198.94 | -3,536.19 | -105.42 | -147.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,817.6 | 158.19 | 4,36,103.12 | 863.29 | 0.74 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,783.75 | 83.58 | 1,53,540.39 | 518 | 0.52 | 2,302 | 513.62 |
Mankind Pharma Ltd MANKIND | 2,910.4 | 59.91 | 1,20,073.47 | 634.43 | 0 | 2,529.74 | 334.18 |
Cipla Ltd CIPLA | 1,475.9 | 28.16 | 1,19,195.76 | 1,178.16 | 0.88 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,401.2 | 70.36 | 1,15,106.89 | 460 | 0.82 | 2,376 | 222.38 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Atul Maheshwari
Whole Time Director & CFO
S M Maheshwari
Independent Non Exe. Director
Dhaval J Soni
Independent Director
Chandramohan Bhagavatula
Independent Director
NANDAN SRINATH
Company Sec. & Compli. Officer
Ritesh Pandey.
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Lactose (India) Ltd
Summary
Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad. The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose. In the year 1994, the company undertook an expansion and forward in
Read More
The Lactose India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹219.15 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lactose India Ltd is ₹308.76 Cr. as of 24 Dec ‘24
The PE and PB ratios of Lactose India Ltd is 33.1 and 3.98 as of 24 Dec ‘24
The 52-week high/low is the highest and lowest price at which a Lactose India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Lactose India Ltd is ₹103.55 and ₹247.4 as of 24 Dec ‘24
Lactose India Ltd's CAGR for 5 Years at 68.05%, 3 Years at 77.11%, 1 Year at 101.98%, 6 Month at 19.20%, 3 Month at 46.20% and 1 Month at 23.92%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice